X0708 D/A LIVE 0001807983 Medicenna Therapeutics Corp. 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 416-648-5555 CANADA (FEDERAL LEVEL) A2 Acquisition Corp. None Corporation true 2015 FAHAR MERCHANT 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Executive Officer Director ELIZABETH WILLIAMS 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Executive Officer CHANDRA PANCHAL 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Director ALBERT G. BERALDO 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Director KAREN DAWES 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Director ROSEMINA MERCHANT 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Director ANDREW STRONG 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 Director Biotechnology Decline to Disclose 06b true 0001807983-20-000001 2020-03-17 false true false 0 HAYWOOD SECURITIES (USA) INC. 849696 HAYWOOD SECURITIES INC. None 200 BURRARD STREET SUITE 700 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 3L6 CA CALIFORNIA CT CONNECTICUT NY NEW YORK PA PENNSYLVANIA false MACKIE RESEARCH USA INC. 39670 MACKIE RESEARCH CAPITAL CORPORATION None 199 BAY STREET, SUITE 4500 COMMERCE COURT WEST TORONTO A6 ONTARIO, CANADA M5L 1G2 CA CALIFORNIA CT CONNECTICUT NY NEW YORK PA PENNSYLVANIA false 9219339 9219339 0 U.S. dollar amounts based on the Bank of Canada average rate of exchange reported on March 17, 2020, which was Cdn$1.4175=US$1.00. false 6 0 true 0 true The Company has granted a 30-day over-allotment option to sell up to an additional 15% of the number of shares sold as part of the offering. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Medicenna Therapeutics Corp. ELIZABETH WILLIAMS ELIZABETH WILLIAMS CHIEF FINANCIAL OFFICER 2020-04-20